The Best Monthly Blood Test Is a Small One

If you want to test monthly, run a small panel of fast-moving analytes and leave everything else on a six- or twelve-month cycle. A twelve-analyte monthly draw plus an annual wide panel gives you more usable signal than a 100-marker panel repeated every month, because most of the extra markers move slower than the assay noise and your own day-to-day biology. The wide “everything” panels sold as subscriptions are fine as a once- or twice-yearly baseline. Repeating them monthly mostly buys you false alarms.

Why most analytes are pointless to repeat monthly

A single lab value carries two kinds of noise. Analytical variation (CVa) is the assay’s own imprecision. Within-subject biological variation (CVi) is how much your true value oscillates around your personal set point across days and weeks. To decide whether two results differ for a real reason, compare their difference to the reference change value:

RCV = 2^0.5 * Z * sqrt(CVa^2 + CVi^2)
# Z = 1.96 for two-sided 95%  ->  RCV ≈ 2.77 * sqrt(CVa^2 + CVi^2)

For an analyte with CVa of 3% and CVi of 6%, a change has to exceed roughly 19% before you should take it seriously. High-sensitivity C-reactive protein (hsCRP) has a within-person CV in the tens of percent, so a doubling month to month is often nothing. Immunological markers in healthy people show the same pattern, with within-subject variation large enough that single measurements poorly represent a person’s set point ¹. This is the core argument for repeated sampling, and also the reason a single monthly number is weak evidence on its own.

Seasonality compounds it. Analysis of NHANES data found systematic seasonal swings in complete blood count parameters and inflammatory markers across the US population ². A white blood cell count that drifts from January to July may be telling you about the calendar rather than about you.

The panel we would draw monthly

We would keep the monthly draw under about fifteen analytes, chosen because they respond on a weeks timescale and because you can act on the trend by changing something measurable.

• Complete blood count with differential. Hemoglobin, hematocrit, mean corpuscular volume, and the neutrophil-to-lymphocyte ratio respond to training load, infection, and iron status within weeks.
• Ferritin plus transferrin saturation (serum iron, total iron-binding capacity). Iron stores move on a monthly timescale under blood loss, endurance training, or supplementation. Ferritin is also an acute-phase reactant, which is why you pair it with hsCRP.
• hsCRP. Noisy per draw, informative as a trend. Treat any single value above your usual band as a prompt to redraw in two weeks. A single high value is not a finding.
• Comprehensive metabolic panel. Creatinine and estimated glomerular filtration rate, ALT, AST, albumin, and electrolytes. ALT in particular tracks hepatic fat and alcohol exposure over weeks.
• Lipid panel with apolipoprotein B. ApoB responds to diet and to any lipid-directed therapy within four to six weeks and has lower biological variation than calculated LDL cholesterol.
• Thyroid-stimulating hormone, with free T4 only if TSH is outside your band.
• 25-hydroxyvitamin D during months when your sun exposure changes.

That set costs roughly $80 to $200 per draw at a direct-access lab in the United States, depending on the state and the vendor. Subscriptions bundling 100-plus markers monthly cost several times that and mostly add analytes whose RCV you will never exceed.

Note what is absent. HbA1c is a poor monthly marker because it integrates roughly 90 to 120 days of glycemia, so consecutive monthly values are heavily autocorrelated. If you want glycemic resolution, wear a continuous glucose monitor. Fasting insulin and related indices are useful for cardiometabolic risk assessment, and they belong on your panel ³, but quarterly is enough.

What belongs on a slower cadence

Once or twice a year, run the wide panel.

• hormone panel
• a fuller nutrient set
• uric acid
• homocysteine
• lipoprotein(a)
• urinalysis
• whatever specialty markers your history warrants

Lipoprotein(a) is largely genetically determined and needs measuring roughly once in a lifetime unless therapy changes.

The same logic applies to the newer blood assays people ask about. Plasma phosphorylated tau assays now identify Alzheimer pathology with accuracy competitive with specialist assessment in primary care populations ⁴. Circulating tumor DNA assays read tumor-derived fragments from plasma ⁵, and machine-learning models on serum thermal profiles have been built for pancreatic cancer detection ⁶. These are screening or diagnostic tools with defined indications and non-trivial false-positive behavior. They are not monthly dashboard metrics, and interpreting a positive result requires a clinician.

Standardizing the draw

Most of the month-to-month variance people chase is pre-analytical. Fix the protocol and your data gets quieter without spending anything.

Draw at the same time of day, ideally between 7 and 9 a.m. Cortisol, testosterone, and serum iron all have strong diurnal rhythms. Fast 12 hours, water allowed, for triglycerides and glucose. Skip hard exercise for 48 hours before the draw. Creatine kinase, AST, and ALT all rise after eccentric loading. Sit quietly for 15 minutes before venipuncture, since moving from supine to upright shifts plasma water out of the vascular space and raises the concentration of every protein-bound analyte. Plasma and red cell volume can themselves be estimated from routine blood markers, which is a useful reminder that hydration state is a measured confounder rather than an unknowable one ⁷.

Use the same lab and the same instrument platform every month. Ferritin, TSH, and testosterone immunoassays differ between manufacturers by amounts larger than the changes you are trying to detect. If you switch labs, treat it as a new series.

Getting the data into a form you can compute on

Ask the lab for results as HL7 FHIR Observation resources or a CSV export with LOINC codes and explicit units. PDF reports are a dead end. If your portal only offers PDF, most US portals support the FHIR patient access API, and you can pull Observation?category=laboratory&patient={id} with a personal access token.

A workable local schema is one row per result with the columns below.

• date
• loinc
• analyte
• value
• unit
• ref_low
• ref_high
• lab_id
• instrument

Store units verbatim and convert in code, because ferritin in ng/mL and µg/L are equal while cholesterol in mg/dL and mmol/L are not.

For analysis, fit a per-analyte trend rather than eyeballing consecutive points. We use a simple approach: compute a rolling median over the last three draws, estimate your personal CV from the first six to eight draws, and flag a point only when it exceeds the RCV relative to your rolling median. Add a month-of-year term if you have two or more years of data, given the documented seasonal component in CBC and inflammatory markers ². A CUSUM chart on the residuals catches slow drift that no single point would flag.

Questions people also ask

Is there a blood panel that tests for everything? No. Panels are collections of specific assays, and even the largest consumer panels cover a few hundred analytes out of thousands of measurable plasma proteins and metabolites. Breadth also costs specificity: the more markers you run at once, the more out-of-range flags you get by chance alone.

Is it okay to do a blood test every month? Physically, yes for most adults. A standard multi-tube draw is roughly 10 to 30 mL, far below the 470 mL of a whole blood donation. If you are already anemic or donate blood regularly, discuss the schedule with a clinician.

What bloodwork should you get every year? A reasonable annual core starts with CBC with differential, lipids with apolipoprotein B, and a comprehensive metabolic panel. It continues with HbA1c and fasting insulin, TSH, 25-hydroxyvitamin D, and ferritin with iron studies. Fasting glucose, insulin indices, and inflammatory markers carry most of the predictive weight for cardiometabolic outcomes ³. Your personal and family history should drive additions.

How much would a full blood test cost? Self-assembled direct-access panels run about $80 to $250 per draw for the monthly core and $300 to $600 for a broad annual panel. Subscription services charge $365 to $2,000 per year for one or two wide panels plus an interpretation layer.

What is the best overall blood test? There is no single best test. The best measurement strategy is a small standardized panel repeated often, which establishes your personal set points. Layer that under a wide annual panel that catches what the small one misses.

Footnotes

1. Najib Aziz, Roger Detels, Joshua J. Quint, et al. Biological variation of immunological blood biomarkers in healthy individuals and quality goals for biomarker tests. BMC Immunology, 2019. https://doi.org/10.1186/s12865-019-0313-0 ↩

2. Bian Liu, Emanuela Taioli. Seasonal Variations of Complete Blood Count and Inflammatory Biomarkers in the US Population - Analysis of NHANES Data. PLOS ONE, 2015. https://doi.org/10.1371/journal.pone.0142382 ↩ ↩²

3. C Herder, M Karakas, W Koenig. Biomarkers for the Prediction of Type 2 Diabetes and Cardiovascular Disease. Clinical Pharmacology & Therapeutics, 2011. https://doi.org/10.1038/clpt.2011.93 ↩ ↩²

4. Sebastian Palmqvist, Pontus Tideman, Niklas Mattsson-Carlgren, et al. Blood Biomarkers to Detect Alzheimer Disease in Primary Care and Secondary Care. JAMA, 2024. https://doi.org/10.1001/jama.2024.13855 ↩

5. Seyed Mohammad Kazem Aghamir, Ramin Heshmat, Mehdi Ebrahimi, et al. Liquid Biopsy: The Unique Test for Chasing the Genetics of Solid Tumors. Epigenetics Insights, 2020. https://doi.org/10.1177/2516865720904052 ↩

6. Sonia Hermoso‐Durán, Nicolas Fraunhoffer, Judith Millastre‐Bocos, et al. Development of a Machine‐Learning Model for Diagnosis of Pancreatic Cancer from Serum Samples Analyzed by Thermal Liquid Biopsy. Advanced Intelligent Systems, 2024. https://doi.org/10.1002/aisy.202400308 ↩

7. Louisa Margit Lobigs, Pierre‐Edouard Sottas, Pitre Collier Bourdon, et al. The use of biomarkers to describe plasma‐, red cell‐, and blood volume from a simple blood test. American Journal of Hematology, 2016. https://doi.org/10.1002/ajh.24577 ↩